Clinisupplies Limited (“Clinisupplies”), a leading manufacturer and supplier of continence care consumables, today announced the acquisition of the Renew Inserts business from Renew Medical Inc. and Renew Medical UK Limited, a US and UK manufacturer of continence products (together “Renew”).
The acquisition of the Renew Inserts range will enable Clinisupplies to expand its bowel management offering, while also supporting patients living with chronic bowel issues through its nursing and homecare services.
Paul Cook, CEO at Clinisupplies, commented: “The Renew Inserts business is a perfect fit with Clinisupplies’ purpose of helping people with continence issues to live more freely through the products and services we provide. It is our ambition to continue broadening the range of products and services in order to reach more consumers and healthcare professionals and to better support their needs. We are excited to add the Renew Inserts range to our portfolio and to continue building on our growing position in the UK and around the world.”
Jason Tate, CEO at Renew, commented: “We have enjoyed a growing and successful commercial partnership with the Clinisupplies team over recent years and have been delighted with the continued success of the Inserts range, both in the UK and Internationally. We are excited to see the next phase of development for the portfolio and the wide ranging support available for Renew Inserts users under Clinisupplies ownership.”
KKR invested in Clinisupplies through KKR Health Care Strategic Growth Fund II, a $4.0 billion fund focused on investing in high-growth health care companies. KKR has a long track record of supporting health care companies globally, having invested more than $20 billion in the sector since 2004.
